Unknown

Dataset Information

0

Investigation of 20S-hydroxyvitamin D3 analogs and their 1?-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities.


ABSTRACT: 20S-hydroxyvitamin D3 [20S(OH)D3] is anti-inflammatory and not hypercalcemic, suggesting its potential as a lead compound. In this study, side chain modified 20S(OH)D3 analogs (4, 13, 23 and 33) together with their 1?-OH derivatives were synthesized and their metabolism and biological activities tested. 4, 13 and 23 are good substrates for CYP27B1, enabling enzymatic synthesis of their 1?-OH derivatives 5, 14 and 24. However, 33 could not be hydroxylated by CYP27B1 and acts as an inhibitor. All analogs were poorer substrates for CYP24A1 than calcitriol, indicating improved catabolic stability. While the parent analogs showed minimal VDR stimulating activity, their 1?-OH derivatives were potent VDR agonists. 4, 5, 14 and 24 significantly upregulated the expression of CYP24A1 at the mRNA level, consistent with their VDR activation abilities and indicating that 1?-hydroxylation is required to produce analogs with strong activity. These analogs have anti-inflammatory activities that are influenced by side chain composition and by 1?-hydroxylation. To understand their molecular interactions with the VDR, 20S(OH)D3, 4 and 33 were co-crystalized with the VDR ligand binding domain, which revealed subtle differences to the calcitriol-bound receptor. This study demonstrates the potential of the 20S(OH)D3 scaffold for the development of novel anti-inflammatory agents.

SUBMITTER: Lin Z 

PROVIDER: S-EPMC5784132 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Investigation of 20S-hydroxyvitamin D<sub>3</sub> analogs and their 1α-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities.

Lin Zongtao Z   Marepally Srinivasa R SR   Goh Emily S Y ESY   Cheng Chloe Y S CYS   Janjetovic Zorica Z   Kim Tae-Kang TK   Miller Duane D DD   Postlethwaite Arnold E AE   Slominski Andrzej T AT   Tuckey Robert C RC   Peluso-Iltis Carole C   Rochel Natacha N   Li Wei W  

Scientific reports 20180124 1


20S-hydroxyvitamin D<sub>3</sub> [20S(OH)D<sub>3</sub>] is anti-inflammatory and not hypercalcemic, suggesting its potential as a lead compound. In this study, side chain modified 20S(OH)D<sub>3</sub> analogs (4, 13, 23 and 33) together with their 1α-OH derivatives were synthesized and their metabolism and biological activities tested. 4, 13 and 23 are good substrates for CYP27B1, enabling enzymatic synthesis of their 1α-OH derivatives 5, 14 and 24. However, 33 could not be hydroxylated by CYP27  ...[more]

Similar Datasets

| S-EPMC8773473 | biostudies-literature
| S-EPMC7426479 | biostudies-literature
| S-EPMC4659745 | biostudies-literature
| S-EPMC4765962 | biostudies-literature
| S-EPMC6563605 | biostudies-literature
| S-EPMC4724233 | biostudies-literature
| S-EPMC8215352 | biostudies-literature
| S-EPMC6371206 | biostudies-literature
| S-EPMC7694157 | biostudies-literature
| S-EPMC2937189 | biostudies-literature